The Cooper Companies, Inc. (NYSE: COO) announced that CooperSurgical has acquired the commercial assets of Recombine Inc., a clinical genetic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE